Post-approval studies (Phase 4)Study completedNCT00496470
What this trial is testing
Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.
Who this might be right for
Chronic Obstructive Pulmonary Disease, COPD
AstraZeneca 660